Sedana Medical AB (publ), interim report Q3, 2020
Positive clinical study – on the way towards our visionFinancial Summary July - September · Net sales during the third quarter amounted to KSEK 21 432 (16 416) corresponding to an increase of 31% compared with the same period in 2019. · Earnings before interest, taxes, depreciation and amortization (EBITDA) amounted to KSEK -10 417 (-4 029). This corresponds to an EBITDA margin of -48,6% (-24,5%). · Earnings before interest and taxes (EBIT) amounted to KSEK -11 700 (-5 093) which corresponds to an EBIT margin of -54,6% (-31,0%). · Net income for the period was KSEK -13 423 (-4